Related Experiment Video
Updated: Jul 27, 2026

A Saline/Bipolar Radiofrequency Energy Device As an Adjunct for Hemostasis in Solid Organ Injury/Trauma
Published on: July 28, 2020
[Potentiated polarized liquid therapy and heart emergency]
1Emergency Department, First Teaching Hospital, Xian Medical University.
Potassium and Magnesium aspartate injections may enhance the effects of glucose, insulin, and potassium chloride solutions. This combination showed remarkable efficacy in treating patients with critical heart conditions and other diseases.
Area of Science:
- Biochemistry
- Cardiology
- Clinical Medicine
Context:
- Potassium and Magnesium ions are vital cations involved in metabolic processes.
- The study investigates the potentiation of a GIK (Glucose, Insulin, Potassium Chloride) solution.
Purpose:
- To evaluate the clinical efficacy and preliminary mechanism of a potentiated GIK (GIKL) solution.
- To assess the impact of Potassium and Magnesium aspartate on GIK solution effects.
Summary:
- A potentiated GIK solution (GIKL) including Kalii L-aspartatis and Magnesii L-aspartatis was administered to 72 patients.
- The GIKL treatment demonstrated remarkable efficacy in patients with heart emergencies and critical illnesses.
- Potential benefits include reduced blood carbon dioxide and ammonia levels.
Impact:
- This preliminary study suggests GIKL as a potentially effective treatment for critical conditions.
- Further research is warranted to fully elucidate the clinical applications and mechanisms of GIKL.
More Related Videos
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
08:21Functional Assessment of the Donor Heart During Ex Situ Perfusion: Insights from Pressure-Volume Loops and Surface Echocardiography
Published on: October 11, 2022
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Introduction Cardiac Emergencies
Cardiopulmonary Resuscitation IV: Pharmacological Management
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Cardiomyopathy II: Dilated Cardiomyopathy